Compare Vaccine Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Gilead Sciences	Johnson & Johnson	Moderna	Novavax	Pfizer
Symbol	NASDAQ:GILD	NYSE:JNJ	NASDAQ:MRNA	NASDAQ:NVAX	NYSE:PFE
Price Information
Current Price	$65.11	$161.25	$140.92	$179.74	$36.60
52 Week Range	Buy	Buy	Hold	Buy	Hold
MarketRank™
Overall Score	2.8	2.7	1.6	1.6	2.4
Analysis Score	4.3	3.4	2.2	3.4	2.1
Community Score	3.3	2.5	3.0	3.1	2.9
Dividend Score	3.3	4.2	0.0	0.0	3.3
Ownership Score	1.7	1.7	0.8	0.8	1.7
Earnings & Valuation Score	1.3	1.9	1.9	0.6	1.9
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	Buy	Hold
Consensus Price Target	$97.23	$180.64	$149.65	$229.64	$38.57
% Upside from Price Target	49.33% upside	12.03% upside	6.19% upside	27.76% upside	5.39% upside
Trade Information
Market Cap	$81.98 billion	$424.52 billion	$56.44 billion	$13.28 billion	$204.14 billion
Beta	0.51	0.7	1.73	2.01	0.7
Average Volume	8,620,099	8,134,383	11,728,641	4,223,301	32,328,539
Sales & Book Value
Annual Revenue	$22.45 billion	$82.06 billion	$60.21 million	$18.66 million	$51.75 billion
Price / Sales	3.65	5.17	937.42	711.44	3.94
Cashflow	$7.72 per share	$11.76 per share	N/A	N/A	$4.08 per share
Price / Cash	8.43	13.71	N/A	N/A	8.97
Book Value	$17.90 per share	$22.60 per share	$3.49 per share	($5.75) per share	$11.46 per share
Price / Book	3.64	7.13	40.38	-31.26	3.19
Profitability
Net Income	$5.39 billion	$15.12 billion	$-514,020,000.00	$-132,690,000.00	$16.27 billion
EPS	$6.14	$8.68	($1.55)	($5.80)	$2.95
Trailing P/E Ratio	67.12	25.35	N/A	N/A	23.61
Forward P/E Ratio	9.29	18.14	13.49	10.18	11.96
P/E Growth	0.67	3.06	0.53	N/A	2.79
Net Margins	5.48%	21.01%	-242.73%	-133.10%	17.85%
Return on Equity (ROE)	37.77%	34.64%	-28.11%	-1,346.17%	24.88%
Return on Assets (ROA)	12.76%	13.40%	-20.31%	-45.85%	9.32%
Dividend
Annual Payout	$2.84	$4.04	N/A	N/A	$1.56
Dividend Yield	4.36%	2.51%	N/A	N/A	4.26%
Three-Year Dividend Growth	30.77%	19.88%	N/A	N/A	-10.94%
Payout Ratio	46.25%	46.54%	N/A	N/A	52.88%
Years of Consecutive Dividend Growth	1 Years	59 Years	N/A	N/A	1 Years
Debt
Debt-to-Equity Ratio	1.65%	0.51%	0.04%	3.61%	0.76%
Current Ratio	3.25%	1.48%	2.43%	2.81%	1.40%
Quick Ratio	3.15%	1.24%	2.43%	2.81%	1.13%
Ownership Information
Institutional Ownership Percentage	76.36%	67.25%	51.21%	49.91%	67.36%
Insider Ownership Percentage	0.13%	0.27%	29.20%	3.30%	0.08%
Miscellaneous
Employees	13,600	134,500	1,300	792	88,300
Shares Outstanding	1.26 billion	2.63 billion	400.53 million	73.86 million	5.58 billion
Next Earnings Date	4/29/2021 (Estimated)	4/20/2021 (Confirmed)	5/6/2021 (Estimated)	5/10/2021 (Estimated)	5/4/2021 (Confirmed)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Latest Vaccine News

Source	Headline
	Pfizer asks US to allow more kids to get vaccine - WAFB wafb.com - April 11 at 10:15 PM
	NET Health announces 1st-dose Pfizer vaccine clinics in Tyler for week of April 12 - KLTV kltv.com - April 11 at 10:15 PM
	Local parents will get teens vaccinated if Pfizer gets emergency use approval - nbc25news.com nbc25news.com - April 11 at 10:15 PM
	Covid variant from South Africa was able to ‘break through’ Pfizer vaccine in Israeli study - CNBC cnbc.com - April 11 at 10:15 PM
	Top China official admits its COVID-19 vaccines have low effectiveness finance.yahoo.com - April 11 at 10:15 PM
	Pfizer asks U.S. to authorize its COVID vaccine for kids 12-15 - NJ.com nj.com - April 11 at 5:14 PM
	How much can Netanyahu squeeze the lemon that is Pfizer CEO? - Haaretz haaretz.com - April 11 at 5:14 PM
	Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’: Doctor - Yahoo Finance finance.yahoo.com - April 11 at 12:14 PM
	What are the side-effects of the Pfizer vaccine? - NHK WORLD www3.nhk.or.jp - April 11 at 12:14 PM
	COVID In Colorado: Centura Health Switches From Johnson & Johnson To Pfizer & Moderna Vaccines - CBS Denver denver.cbslocal.com - April 11 at 12:14 PM
	The Pfizer/BioNTech Covid-19 Vaccine Is Less Effective Against The South African And UK Variants Than Against The Original Virus, According To A New “real-World” Study From Israel - Forbes forbes.com - April 11 at 12:14 PM
	UPDATE 1-South African variant may evade protection from Pfizer vaccine, Israeli study says finance.yahoo.com - April 11 at 12:14 PM
	China considering mixing COVID-19 vaccines to boost protection rate financialpost.com - April 11 at 10:43 AM
	Pfizer requests emergency use authorization to administer COVID-19 vaccine to teens - WREX-TV wrex.com - April 11 at 7:13 AM
	Centura transitions three vaccine sites to Moderna and Pfizer only - 9News.com KUSA 9news.com - April 11 at 7:13 AM
	Israeli Study Shows Pfizer Vaccine Less Effective Against South African Variant - http://hamodia.com hamodia.com - April 11 at 7:13 AM
	3 Great Dividend Stocks to Buy Right Now finance.yahoo.com - April 11 at 7:13 AM
	COVID: Pfizer asks FDA to authorize vaccine for children 12 to 15 years old - The Mercury News mercurynews.com - April 10 at 10:37 PM
	Pfizer, doctors push for children to get COVID shot - KGW.com kgw.com - April 10 at 10:37 PM
	Pfizer asks FDA to allow its COVID-19 vaccine for younger teens - MyFoxZone.com KIDY myfoxzone.com - April 10 at 10:37 PM
	Pfizer Requests FDA Approval to Use Its COVID Vaccine in Kids Ages 12 to 15 - PEOPLE people.com - April 10 at 5:36 PM
	South African Variant Can 'Break Through' Pfizer Vaccine, Israeli Study Says - U.S. News & World Report usnews.com - April 10 at 5:36 PM
	Pfizer aims to offer COVID vaccine to children in time for 2021 school year, if authorized - 11Alive.com WXIA 11alive.com - April 10 at 5:36 PM
	South African variant can ‘break through’ Pfizer vaccine, Israeli study says financialpost.com - April 10 at 4:21 PM
	The Latest: Vaccine shortages hitting poor countries marketbeat.com - April 10 at 2:13 PM
	Pfizer said to warn Israel: Pay up or go to the back of vaccine line - The Times of Israel timesofisrael.com - April 10 at 12:36 PM
	The Latest: Pfizer asks US to allow more kids to get vaccine marketbeat.com - April 9 at 5:03 PM
	Australia to buy extra 20 million doses of Pfizer vaccine marketbeat.com - April 9 at 12:57 AM
	Australia halts AstraZeneca vaccine for most people under 50 marketbeat.com - April 8 at 7:28 AM
	Pfizer (NYSE:PFE) Now Covered by Analysts at Royal Bank of Canada marketbeat.com - April 7 at 8:44 AM
	The Latest: Arizona AG says governor can't block mask rules marketbeat.com - April 6 at 9:45 PM
	The Latest: Wife of Montana governor also tests positive marketbeat.com - April 6 at 7:19 PM
	The Latest: Tennessee governor opposes vaccine passports marketbeat.com - April 6 at 6:14 PM
	The Latest: Chile delays several elections amid virus surge marketbeat.com - April 6 at 5:04 PM
	The Latest: California aims to reopen more widely in June marketbeat.com - April 6 at 3:45 PM
	The Latest: Turkey's daily virus cases reach nearly 50,000 marketbeat.com - April 6 at 3:29 PM
	The Latest: WH: No credential to show if vaccinated marketbeat.com - April 6 at 2:57 PM
	The Latest: WH: 28M vaccines doses to states this week marketbeat.com - April 6 at 1:39 PM
	The Latest: WH: 28M vaccine doses to states this week marketbeat.com - April 6 at 1:38 PM
	The Latest: Study: Moderna vaccine lasts at least 6 months marketbeat.com - April 6 at 12:31 PM
	Young professionals cut ahead of older Italians for vaccine marketbeat.com - April 3 at 2:35 AM
	Dutch temporarily halt AstraZeneca shots for under-60s marketbeat.com - April 2 at 11:47 AM
	The Latest: France orders school closure, travel ban marketbeat.com - March 31 at 3:28 PM
	The Latest: Coronavirus pushed US deaths past 3.3M last year marketbeat.com - March 31 at 2:16 PM
	The Latest: Wisconsin Supreme Court strikes mask mandate marketbeat.com - March 31 at 11:52 AM
	The Latest: China pushes virus origin search beyond border marketbeat.com - March 31 at 9:58 AM
	The Latest: Pfizer: Vaccine safe in kids as young as 12 marketbeat.com - March 31 at 8:38 AM
	Pfizer says COVID-19 vaccine protects kids as young as 12, which could open door for expanded use in children by fall marketbeat.com - March 31 at 7:08 AM
	Pfizer says its COVID-19 vaccine protects younger teens marketbeat.com - March 31 at 7:08 AM
	The Latest: Italy orders 5-day quarantine on entries from EU marketbeat.com - March 30 at 10:22 AM

Latest Vaccine Analyst Ratings

Date	Company	Brokerage	Action
4/1/2021	Gilead Sciences	Sanford C. Bernstein	Upgrade
3/30/2021	Gilead Sciences	Redburn Partners	Upgrade
2/11/2021	Gilead Sciences	SVB Leerink	Lower Price Target
2/5/2021	Gilead Sciences	Credit Suisse Group	Boost Price Target
2/5/2021	Gilead Sciences	Morgan Stanley	Boost Price Target
1/4/2021	Gilead Sciences	Guggenheim	Upgrade
12/22/2020	Gilead Sciences	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Lower Price Target
12/22/2020	Gilead Sciences	Smith Barney Citigroup	Lower Price Target
12/18/2020	Gilead Sciences	Truist Financial	Lower Price Target
12/17/2020	Gilead Sciences	Oppenheimer	Lower Price Target
12/16/2020	Gilead Sciences	BMO Capital Markets	Lower Price Target
12/16/2020	Gilead Sciences	Robert W. Baird	Boost Price Target
12/15/2020	Gilead Sciences	Piper Sandler	Lower Price Target
12/8/2020	Gilead Sciences	JPMorgan Chase & Co.	Reiterated Rating
10/29/2020	Gilead Sciences	Cantor Fitzgerald	Reiterated Rating
10/29/2020	Gilead Sciences	Barclays	Lower Price Target
10/29/2020	Gilead Sciences	Wells Fargo & Company	Lower Price Target
1/27/2021	Johnson & Johnson	Raymond James	Boost Price Target
1/27/2021	Johnson & Johnson	Cowen	Boost Price Target
8/19/2020	Johnson & Johnson	Stifel Nicolaus	Downgrade
7/20/2020	Johnson & Johnson	Bank of America	Reiterated Rating
7/20/2020	Johnson & Johnson	Independent Research	Upgrade
3/8/2021	Moderna	Chardan Capital	Boost Price Target
3/4/2021	Moderna	Brookline Capital Management	Boost Price Target
2/18/2021	Moderna	Jefferies Financial Group	Boost Price Target
3/18/2021	Novavax	HC Wainwright	Boost Price Target
2/1/2021	Novavax	B. Riley	Boost Price Target
8/5/2020	Novavax	LADENBURG THALM/SH SH	Downgrade
4/7/2021	Pfizer	Royal Bank of Canada	Initiated Coverage
4/6/2021	Pfizer	The Goldman Sachs Group	Set Price Target
3/23/2021	Pfizer	Berenberg Bank	Reiterated Rating
2/3/2021	Pfizer	DZ Bank	Reiterated Rating
2/3/2021	Pfizer	Mizuho	Lower Price Target

(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Vaccine Stocks

Latest Vaccine News

Latest Vaccine Analyst Ratings

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources